
CSCO · Nasdaq
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $63.33B | $56.65B | $53.80B | $57.00B | $51.56B | $49.82B | $49.30B | $51.90B |
| Cost of Revenue | $22.46B | $19.86B | $18.98B | $21.25B | $19.31B | $17.92B | $17.62B | $19.24B |
| Gross Profit | $40.86B | $36.79B | $34.83B | $35.75B | $32.25B | $31.89B | $31.68B | $32.67B |
| Research & Development | $9.56B | $9.30B | $7.98B | $7.55B | $6.77B | $6.55B | $6.35B | $6.58B |
| Selling, General & Administrative | $2.76B | $2.99B | $2.81B | $2.48B | $2.10B | $2.15B | $1.93B | $1.83B |
| Operating Expenses | $25.49B | $25.03B | $22.65B | $20.72B | $18.28B | $19.06B | $18.06B | $18.45B |
| Operating Income | $15.37B | $11.76B | $12.18B | $15.03B | $13.97B | $12.83B | $13.62B | $14.22B |
| Interest Expense | — | — | — | $427.00M | $360.00M | $434.00M | $585.00M | $859.00M |
| Other Income / (Expense) | $641.00M | -$660.00M | $53.00M | $287.00M | $508.00M | $429.00M | $350.00M | $352.00M |
| Income Before Taxes | $16.01B | $11.10B | $12.23B | $15.32B | $14.48B | $13.26B | $13.97B | $14.57B |
| Provision for Income Taxes | $2.74B | $920.00M | $1.91B | $2.71B | $2.67B | $2.67B | $2.76B | $2.95B |
| Net Income | $13.27B | $10.18B | $10.32B | $12.61B | $11.81B | $10.59B | $11.21B | $11.62B |
| Basic EPS | $3.36 | $2.56 | $2.55 | $3.08 | $2.83 | $2.51 | $2.65 | $2.63 |
| Diluted EPS | $3.33 | $2.55 | $2.54 | $3.07 | $2.82 | $2.50 | $2.64 | $2.61 |
| Basic Shares Outstanding | 3.95B | 3.98B | 4.04B | 4.09B | 4.17B | 4.22B | 4.24B | 4.42B |
| Diluted Shares Outstanding | 3.99B | 4.00B | 4.06B | 4.11B | 4.19B | 4.24B | 4.25B | 4.45B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jul 2026 | $3.54 | $3.32 | $3.64 | 8 | ↑1 ↓1 |
| Jul 2027 | $4.43 | $4.19 | $4.77 | 9 | ↑0 ↓0 |
| Jul 2028 | $4.79 | $4.47 | $5.14 | 9 | ↑2 ↓0 |
| Jul 2029 | $5.17 | $4.89 | $5.45 | 2 | ↑0 ↓0 |